Cargando…
A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA
About 10% of all breast cancers arise from hereditary mutations that increase the risk of breast and ovarian cancers; and about 25% of these are associated with the BRCA1 or BRCA2 genes. The identification of BRCA1/BRCA2 mutations can enable physicians to better tailor the clinical management of pat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187945/ https://www.ncbi.nlm.nih.gov/pubmed/28009814 http://dx.doi.org/10.3390/ijms17122145 |
_version_ | 1782486933086142464 |
---|---|
author | Esposito, Maria Valeria Nunziato, Marcella Starnone, Flavio Telese, Antonella Calabrese, Alessandra D’Aiuto, Giuseppe Pucci, Pietro D’Aiuto, Massimiliano Baralle, Francisco D’Argenio, Valeria Salvatore, Francesco |
author_facet | Esposito, Maria Valeria Nunziato, Marcella Starnone, Flavio Telese, Antonella Calabrese, Alessandra D’Aiuto, Giuseppe Pucci, Pietro D’Aiuto, Massimiliano Baralle, Francisco D’Argenio, Valeria Salvatore, Francesco |
author_sort | Esposito, Maria Valeria |
collection | PubMed |
description | About 10% of all breast cancers arise from hereditary mutations that increase the risk of breast and ovarian cancers; and about 25% of these are associated with the BRCA1 or BRCA2 genes. The identification of BRCA1/BRCA2 mutations can enable physicians to better tailor the clinical management of patients; and to initiate preventive measures in healthy carriers. The pathophysiological significance of newly identified variants poses challenges for genetic counseling. We characterized a new BRCA1 variant discovered in a breast cancer patient during BRCA1/2 screening by next-generation sequencing. Bioinformatic predictions; indicating that the variant is probably pathogenetic; were verified using retro-transcription of the patient’s RNA followed by PCR amplifications performed on the resulting cDNA. The variant causes the loss of a canonic donor splice site at position +2 in BRCA1 intron 21; and consequently the partial retention of 156 bp of intron 21 in the patient’s transcript; which demonstrates that this novel BRCA1 mutation plays a pathogenetic role in breast cancer. These findings enabled us to initiate appropriate counseling and to tailor the clinical management of this family. Lastly; these data reinforce the importance of studying the effects of sequence variants at the RNA level to verify their potential role in disease onset. |
format | Online Article Text |
id | pubmed-5187945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-51879452016-12-30 A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA Esposito, Maria Valeria Nunziato, Marcella Starnone, Flavio Telese, Antonella Calabrese, Alessandra D’Aiuto, Giuseppe Pucci, Pietro D’Aiuto, Massimiliano Baralle, Francisco D’Argenio, Valeria Salvatore, Francesco Int J Mol Sci Article About 10% of all breast cancers arise from hereditary mutations that increase the risk of breast and ovarian cancers; and about 25% of these are associated with the BRCA1 or BRCA2 genes. The identification of BRCA1/BRCA2 mutations can enable physicians to better tailor the clinical management of patients; and to initiate preventive measures in healthy carriers. The pathophysiological significance of newly identified variants poses challenges for genetic counseling. We characterized a new BRCA1 variant discovered in a breast cancer patient during BRCA1/2 screening by next-generation sequencing. Bioinformatic predictions; indicating that the variant is probably pathogenetic; were verified using retro-transcription of the patient’s RNA followed by PCR amplifications performed on the resulting cDNA. The variant causes the loss of a canonic donor splice site at position +2 in BRCA1 intron 21; and consequently the partial retention of 156 bp of intron 21 in the patient’s transcript; which demonstrates that this novel BRCA1 mutation plays a pathogenetic role in breast cancer. These findings enabled us to initiate appropriate counseling and to tailor the clinical management of this family. Lastly; these data reinforce the importance of studying the effects of sequence variants at the RNA level to verify their potential role in disease onset. MDPI 2016-12-21 /pmc/articles/PMC5187945/ /pubmed/28009814 http://dx.doi.org/10.3390/ijms17122145 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Esposito, Maria Valeria Nunziato, Marcella Starnone, Flavio Telese, Antonella Calabrese, Alessandra D’Aiuto, Giuseppe Pucci, Pietro D’Aiuto, Massimiliano Baralle, Francisco D’Argenio, Valeria Salvatore, Francesco A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA |
title | A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA |
title_full | A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA |
title_fullStr | A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA |
title_full_unstemmed | A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA |
title_short | A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA |
title_sort | novel pathogenic brca1 splicing variant produces partial intron retention in the mature messenger rna |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187945/ https://www.ncbi.nlm.nih.gov/pubmed/28009814 http://dx.doi.org/10.3390/ijms17122145 |
work_keys_str_mv | AT espositomariavaleria anovelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT nunziatomarcella anovelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT starnoneflavio anovelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT teleseantonella anovelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT calabresealessandra anovelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT daiutogiuseppe anovelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT puccipietro anovelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT daiutomassimiliano anovelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT barallefrancisco anovelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT dargeniovaleria anovelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT salvatorefrancesco anovelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT espositomariavaleria novelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT nunziatomarcella novelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT starnoneflavio novelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT teleseantonella novelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT calabresealessandra novelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT daiutogiuseppe novelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT puccipietro novelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT daiutomassimiliano novelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT barallefrancisco novelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT dargeniovaleria novelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna AT salvatorefrancesco novelpathogenicbrca1splicingvariantproducespartialintronretentioninthematuremessengerrna |